Tocilizumab in Giant Cell Arteritis: A Multicenter Retrospective Study of 34 Patients

被引：48

作者：

Regent, Alexis ^{[1
]}

Redeker, Serge ^{[2
]}

Deroux, Alban ^{[3
]}

Kieffer, Pierre ^{[4
]}

Ly, Kim Heang ^{[5
]}

Dougados, Maxime ^{[6
]}

Liozon, Eric ^{[5
]}

Larroche, Claire ^{[7
]}

Guillevin, Loic ^{[1
]}

Bouillet, Laurence ^{[3
]}

Espitia, Olivier ^{[8
]}

Costedoat-Chalumeau, Nathalie ^{[1
]}

Soubrier, Martin ^{[9
]}

Brihaye, Benoit ^{[10
]}

Lifermann, Francois ^{[11
]}

Lefevre, Guillaume ^{[12
]}

Puechal, Xavier ^{[13
,14
]}

Mouthon, Luc ^{[13
,14
]}

Toussirot, Eric ^{[15
]}

机构：

[1] Univ Paris 05, Hop Cochin, APHP, Ctr Reference Malad Autoimmunes & Syst Rares,Serv, Paris, France

[2] Ctr Hosp Abbeville, Serv Med Interne, Abbeville, France

[3] Univ Grenoble Alpes, Serv Med Interne, CHU Grenoble, Grenoble, France

[4] Ctr Hosp Gen Mulhouse, Serv Med Interne, Mulhouse, France

[5] CHU Limoges, Serv Med Interne, Limoges, France

[6] Univ Paris 05, Hop Cochin, APHP,INSERM,PRES Sorbonne Paris Cite, Clin Epidemiol & Biostat,Dept Rheumatol,U1153, Paris, France

[7] Hop Avicenne, Serv Med Interne, Avicenne, France

[8] Hop Hotel Dieu, Serv Med Interne, Paris, France

[9] CHU Clermont Ferrand, Serv Rhumatol, Clermont Ferrand, France

[10] Hop St Quentin, Serv Med Interne & Med Polyvalente, Paris, France

[11] CH Dax, Serv Med Interne, Dax, France

[12] Hop Claude Huriez, Serv Med Interne, Paris, France

[13] Univ Paris 05, Paris, France

[14] Hop Cochin, APHP, Serv Med Interne, Ctr Reference Malad Autoimmunes & Syst Rares, Paris, France

[15] CHRU, INSERM CIC 1431, FHU INCREASE,Serv Rhumatol, Ctr Invest Clin Biotherapie, Paris, France

来源：

JOURNAL OF RHEUMATOLOGY | 2016年 / 43卷 / 08期

关键词：

GIANT CELL ARTERITIS; TOCILIZUMAB; BIOLOGICAL THERAPY; LARGE-VESSEL VASCULITIS; INTERLEUKIN-6;

D O I：

10.3899/jrheum.151252

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objective. To report the efficacy and safety of tocilizumab (TCZ) for giant cell arteritis (GCA). Methods. A retrospective multicenter study that included 34 patients receiving TCZ for GCA. Results. TCZ was effective in all but 6 patients, who still had mild symptoms. Mean glucocorticoid dose was tapered. One patient died and 3 patients had to stop TCZ therapy because of severe adverse events. Twenty-three patients stopped treatment; 8 of these experienced relapses after a mean of 3.5 +/- 1.3 months. Conclusion. TCZ is effective in GCA. However, side effects occur. Whether this treatment has only a suspensive effect remains to be determined.

引用

页码：1547 / 1552

页数：6

共 50 条

[1] Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients
Loricera, Javier
Castaneda, Santos
Moriano, Clara
Narvaez, Javier
Aldasoro, Vicente
Maiz, Olga
Melero, Rafael
Villa, Ignacio
Vela, Paloma
Romero-Yuste, Susana
Callejas, Jose L.
de Miguel, Eugenio
Galindez-Agirregoikoa, Eva
Sivera, Francisca
Fernandez-Lopez, Jesus C.
Galisteo, Carles
Ferraz-Amaro, Ivan
Sanchez-Martin, Julio
Sanchez-Bilbao, Lara
Calderon-Goercke, Monica
Casado, Alfonso
Hernandez, Jose L.
Gonzalez-Gay, Miguel A.
Blanco, Ricardo
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2022, 14
[2] TREATMENT OF GIANT CELL ARTERITIS WITH TOCILIZUMAB: A RETROSPECTIVE COHORT STUDY OF 119 PATIENTS
Rakholiya, J.
Koster, M.
Langenfeld, H.
Crowson, C. S.
Abril, A.
Bansal, P.
Mertz, L.
Rodriguez-Pla, A.
Sehgal, R.
Wang, B.
Warrington, K. J.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 655 - 655
[3] Treatment of Giant Cell Arteritis with Tocilizumab: A Retrospective Cohort Study of 119 Patients
Rakholiya, Jigisha
Koster, Matthew
Langenfeld, Hannah
Crowson, Cynthia
Abril, Andy
Bansal, Pankaj
Mertz, Lester
Pla, Alicia Rodriguez
Sehgal, Rahul
Wang, Benjamin
Warrington, Kenneth
ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2923 - 2925
[4] Tocilizumab in giant cell arteritis: a multicentre open-label study of 34 patients
Regent, A.
Redeker, S.
Deroux, A.
Kieffer, P.
Ly, K.
Dougados, M.
Liozon, E.
Larroche, C.
Guillevin, L.
Bouillet, L.
Espitia, O.
Costeodat-Chalumeau, N.
Soubrier, M.
Brihaye, B.
Liferman, F.
Lefevre, G.
Puechal, X.
Mouthon, L.
Toussirot, E.
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2016, 30 : 7 - 7
[5] Utility of Optimization of Tocilizumab Therapy in Giant Cell Arteritis: A Multicenter Study of 471 Patients
Benavides Villanueva, Fabricio
Corrales, Cristina
Loricera, Javier
Calderon-Goercke, Monica
Moriano, Clara
Castaneda, Santos
Javier Narvaez, Francisco
Aldasoro, Vicente
Maiz, Olga
Melero, Rafael
Ignacio Villa, Juan
Vela-Casampere, Paloma
Romero Yuste, Susana
Luis Callejas, Jose
De Miguel, Eugenio
Galindez-Agirregoikoa, Eva
Sivera, Francisca
Carlos Fernandez-Lopez, Jesus
Galisteo, Carles
Ferraz Amaro, Ivan
Sanchez Martin, Julio
Sanchez-Bilbao, Lara
Luis Hernandez, Jose
Gonzalez Gay, Miguel Angel
Blanco, Ricardo
ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 944 - 946
[6] Tocilizumab in giant cell arteritis: Multicenter open-label study of 22 patients
Loricera, Javier
Blanco, Ricardo
Hernandez, Jose L.
Castaneda, Santos
Mera, Antonio
Perez-Pampin, Eva
Peiro, Enriqueta
Humbria, Alicia
Calvo-Alen, Jaime
Aurrecoechea, Elena
Narvaez, Javier
Sanchez-Andrade, Amalia
Vela, Paloma
Diez, Elvira
Mata, Cristina
Lluch, Pau
Moll, Concepcion
Hernandez, Inigo
Calvo-Rio, Vanesa
Ortiz-Sanjuan, Francisco
Gonzalez-Vela, Carmen
Pina, Trinitario
Gonzalez-Gay, Miguel A.
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2015, 44 (06) : 717 - 723
[7] TOCILIZUMAB IN GIANT CELL ARTERITIS: A MULTICENTRE OPEN-LABEL STUDY OF34 PATIENTS
Regent, A.
Redeker, S.
Deroux, A.
Kieffer, P.
Ly, K.
Dougados, M.
Eric, L.
Larroche, C.
Guillevin, L.
Bouillet, L.
Espitia, O.
Costedoat-Chalumeau, N.
Soubrier, M.
Brihaye, B.
Liferman, F.
Lefebvre, G.
Puechal, X.
Mouthon, L.
Toussirot, E.
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 794 - 794
[8] Tocilizumab in Giant Cell Arteritis: A Real-Life Retrospective Study
Vitiello, Gianfranco
Battaglini, Carolina Orsi
Carli, Giulia
Radice, Anna
Matucci, Andrea
Vultaggio, Alessandra
Olianti, Catia
Parronchi, Paola
Maggi, Enrico
Cammelli, Daniele
ANGIOLOGY, 2018, 69 (09) : 763 - 769
[9] Tocilizumab in Giant Cell Arteritis: Multicenter Open-Label Study of 22 Patients.
Santos-Gomez, Montserrat
Loricera, Javier
Blanco, Ricardo
Hernandez, Jose L.
Mera, Antonio
Perez-Pampin, Eva
Enriqueta Peiro, M.
Castaneda-Sanz, Santos
Humbria, Alicia
Calvo-Alen, Jaime
Aurrecoechea, Elena
Narvaez, Javier
Sanchez-Andrade, Amalia
Vela, Paloma
Diez Alvarez, Elvira
Mata, Cristina
Lluch Mesquida, Pablo
Moll Tuduri, Concepcion
Calvo-Rio, Vanesa
Ortiz-Sanjuan, Francisco
Pina Murcia, Trinitario
Gonzalez-Vela, Carmen
Riancho-Zarrabeitia, Leyre
Gonzalez-Gay, Miguel A.
ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S357 - S357
[10] Tocilizumab in Giant Cell Arteritis. National Multicenter Study of 134 Patients of Clinical Practice
Calderon Goercke, Monica
Loricera, Javier
Prieto Pena, Diana
Aldasoro, Vicente
Castaneda, Santos
Villa-Blanco, Ignacio
Humbria, Alicia
Moriano Morales, Clara
Romero-Yuste, Susana
Javier Narvaez, Francisco
Gomez-Arango, Catalina
Perez Pampin, Eva
Melero, Rafael
Becerra-Fernandez, Elena
Revenga-Martinez, Marcelino
Alvarez-Rivas, Noelia
Galisteo, Carlos
Sivera, Francisca
Olive-Marques, Alejandro
Alvarez de Buergo, Maria Concepcion
Rojas Vargas, Luisa Marena
Fernandez-Lopez, Carlos
Navarro, Francisco
Rata Alvarez, Enrique
Galindez-Agirregoikoa, Eva
Arca, Beatriz
Solans, Roser
Conesa, Arantxa
Hidalgo-Calleja, Cristina
Vazquez, Carlos
Ortiz-Sanjuan, Francisco
Lluch, Pau
Manrique-Arija, Sara
Vela, Paloma
De Miguel, Eugenio
Torres-Martin, Carmen
Carlos Nieto, Juan
Ordas-Calvo, Carmen
Salgado-Perez, Eva
Varela-Garcia, Maria
Gomez, Cristina Luna
Saenz de Miera, Francisco J. Tovos
Fernandez-Llanio Cornella, Nagore
Roman Ivorra, Jose Andres
Garcia, Antonio
Palmou-Fontana, Natalia
Calvo-Rio, Vanesa
Luis Martin-Varillas, Jose
Atienza-Mateo, Belen
Gonzalez-Vela, Carmen
ARTHRITIS & RHEUMATOLOGY, 2018, 70

← 1 2 3 4 5 →